Pacific Biosciences Of California (PACB) Change in Accured Expenses (2010 - 2026)

Pacific Biosciences Of California's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 1550.16% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $3.6 million (up 259.26% YoY), while the FY2025 annual figure was -$1.2 million, up 95.47% from the prior year.
• Change in Accured Expenses was $5.1 million for Q1 2026 at Pacific Biosciences Of California, up from $1.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $22.7 million in Q2 2024 to a low of -$23.8 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged -$494882.4 across 5 years, with a median of $188000.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses plunged 867.54% in 2024, then surged 1550.16% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at $11.9 million in 2022, then fell by 7.48% to $11.0 million in 2023, then slumped by 274.59% to -$19.3 million in 2024, then surged by 105.32% to $1.0 million in 2025, then surged by 400.19% to $5.1 million in 2026.
• The last three Change in Accured Expenses figures came in at $5.1 million (Q1 2026), $1.0 million (Q4 2025), and $188000.0 (Q3 2025), per Business Quant data.